Mark G. Kris, MD, Discusses Emerging Targets and Treatments for Lung Cancer
January 4th 2013
Mark G. Kris, MD, offers insight into NSCLC related topics, including emerging therapeutic targets, the optimal application of TKIs, strategies for patients with poor performance status, maintenance therapies, and the treatment pipeline.